Reply to: Effect of statins on measures of coagulation-potential role of low-density lipoprotein receptors

Joseph S Biedermann^{1

2}, Willem M Lijfering³

Affiliations

¹ Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
² Star-Medical Anticoagulation Clinic, Rotterdam, The Netherlands.
³ Department of Clinical Epidemiology, Leiden University Medical Center, RC Leiden, The Netherlands.

Comment

Joseph S Biedermann et al. Eur Heart J. 2019.

. 2019 Jan 21;40(4):393.

doi: 10.1093/eurheartj/ehy681.

Joseph S Biedermann^{1

2}, Willem M Lijfering³

¹ Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
² Star-Medical Anticoagulation Clinic, Rotterdam, The Netherlands.
³ Department of Clinical Epidemiology, Leiden University Medical Center, RC Leiden, The Netherlands.

No abstract available

Comment on

Rosuvastatin use improves measures of coagulation in patients with venous thrombosis.
Biedermann JS, Kruip MJHA, van der Meer FJ, Rosendaal FR, Leebeek FWG, Cannegieter SC, Lijfering WM. Biedermann JS, et al. Eur Heart J. 2018 May 14;39(19):1740-1747. doi: 10.1093/eurheartj/ehy014. Eur Heart J. 2018. PMID: 29394348 Clinical Trial.
Effect of statins on measures of coagulation: potential role of low-density lipoprotein receptors.
Paciullo F, Gresele P. Paciullo F, et al. Eur Heart J. 2019 Jan 21;40(4):392. doi: 10.1093/eurheartj/ehy680. Eur Heart J. 2019. PMID: 30339179 No abstract available.